Xencor (XNCR) Current Assets (2013 - 2026)
Xencor's (XNCR) quarterly Current Assets came in at $482.9 million in Q1 2026, down 7.37% year-on-year from $521.3 million in Q1 2025, and down 19.5% on a QoQ basis from $599.8 million in Q4 2025.
Xencor (XNCR) Current Assets (2013 - 2026) Analysis & Trends
Xencor (XNCR) has 14 years of Current Assets data on file, last reported at $482.9 million in Q1 2026.
- On a quarterly basis, Current Assets fell 7.37% year-over-year to $482.9 million in Q1 2026; TTM through Mar 2026 was $482.9 million, a 7.37% decrease from a year earlier, with the FY2025 full-year figure at $599.8 million, up 3.85% from the prior year.
- Current Assets for Q1 2026 stood at $482.9 million, down from $599.8 million in the prior quarter.
- Over the last five years, Current Assets for XNCR reached as high as $675.3 million in Q4 2022 and fell as low as $482.9 million in Q1 2026.
- Historically, Current Assets has averaged $577.2 million across 5 years, with a median of $577.6 million in 2024.
- Across the five-year window, Current Assets surged 102.65% in 2022 and dropped 14.49% in 2023, its largest moves.
- Year by year, Current Assets stood at $675.3 million in 2022, then retreated by 5.88% to $635.6 million in 2023, then retreated by 9.13% to $577.6 million in 2024, then advanced by 3.85% to $599.8 million in 2025, then slipped by 19.5% to $482.9 million in 2026.
- Per Business Quant data, the three most recent Current Assets figures were $482.9 million in Q1 2026, $599.8 million in Q4 2025, and $518.4 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 289.93 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 73.04 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 6.60 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 35.73 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 11.73 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 18.21 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 521.86 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 8.07 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 1.97 Bn |
| 10 | Xencor | 1.47 Bn | 1.09 Bn | - | 482.86 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 482.86 Mn |
| Dec 31, 2025 | 599.82 Mn |
| Sep 30, 2025 | 518.44 Mn |
| Jun 30, 2025 | 513.15 Mn |
| Mar 31, 2025 | 521.27 Mn |
| Dec 31, 2024 | 577.60 Mn |
| Sep 30, 2024 | 589.60 Mn |
| Jun 30, 2024 | 568.92 Mn |
| Mar 31, 2024 | 574.85 Mn |
| Dec 31, 2023 | 635.60 Mn |
| Sep 30, 2023 | 571.18 Mn |
| Jun 30, 2023 | 593.56 Mn |
| Mar 31, 2023 | 629.98 Mn |
| Dec 31, 2022 | 675.34 Mn |
| Sep 30, 2022 | 668.00 Mn |
| Jun 30, 2022 | 585.94 Mn |
| Mar 31, 2022 | 505.97 Mn |
| Dec 31, 2021 | 424.37 Mn |
| Sep 30, 2021 | 329.63 Mn |
| Jun 30, 2021 | 480.97 Mn |